Fatima Cardoso
Fatima Cardoso
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal
Verified email at fundacaochampalimaud.pt
TitleCited byYear
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
22462013
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...
Journal of the National Cancer Institute 98 (4), 262-272, 2006
17692006
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
12772006
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
11892015
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of oncology 26 (suppl_5), v8-v30, 2015
9822015
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
9412007
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E De Azambuja, F Cardoso, G de Castro Jr, M Colozza, MS Mano, ...
British journal of cancer 96 (10), 1504, 2007
8562007
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
J Cortes, J O'Shaughnessy, D Loesch, JL Blum, LT Vahdat, K Petrakova, ...
The Lancet 377 (9769), 914-923, 2011
7852011
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
7242016
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ...
Annals of oncology 25 (10), 1871-1888, 2014
5962014
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Senkus, S Kyriakides, F Penault-Llorca, P Poortmans, A Thompson, ...
Annals of oncology 24 (suppl_6), vi7-vi23, 2013
5372013
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer
S Chan, ME Scheulen, S Johnston, K Mross, F Cardoso, C Dittrich, ...
Journal of Clinical Oncology 23 (23), 5314-5322, 2005
5162005
Clinical application of the 70-gene profile: the MINDACT trial
F Cardoso, L Van't Veer, E Rutgers, S Loi, S Mook, MJ Piccart-Gebhart
Journal of clinical oncology 26 (5), 729-735, 2008
5132008
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
Annals of Oncology 28 (1), 16-33, 2017
4652017
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F Cardoso, N Harbeck, L Fallowfield, S Kyriakides, E Senkus, ...
Annals of oncology 23 (suppl_7), vii11-vii19, 2012
4482012
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2–positive, node-negative tumors 1 cm or smaller
AM Gonzalez-Angulo, JK Litton, KR Broglio, F Meric-Bernstam, R Rakkhit, ...
Journal of clinical oncology 27 (34), 5700, 2009
3922009
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
3702017
Multidisciplinary meeting on male breast cancer: summary and research recommendations
LA Korde, JA Zujewski, L Kamin, S Giordano, S Domchek, WF Anderson, ...
Journal of Clinical Oncology 28 (12), 2114, 2010
3532010
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
D Gancberg, A Di Leo, F Cardoso, G Rouas, M Pedrocchi, M Paesmans, ...
Annals of Oncology 13 (7), 1036-1043, 2002
3532002
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
M Colozza, E Azambuja, F Cardoso, C Sotiriou, D Larsimont, MJ Piccart
Annals of oncology 16 (11), 1723-1739, 2005
3422005
The system can't perform the operation now. Try again later.
Articles 1–20